| Feature Type | Standardized | Nominal ANOVA | ||||
|---|---|---|---|---|---|---|
| mRNA | KX2-391 | CTRPv2 | pan-cancer | AAC | 0.0012 | 1 |
| mRNA | C6-ceramide | CTRPv2 | pan-cancer | AAC | -0.0013 | 1 |
| mRNA | masitinib | CTRPv2 | pan-cancer | AAC | -0.0011 | 1 |
| mRNA | isoliquiritigenin | CTRPv2 | pan-cancer | AAC | 0.002 | 1 |
| mRNA | cediranib | CTRPv2 | pan-cancer | AAC | 0.0016 | 1 |
| mRNA | PD-0325901 | GDSC1000 | pan-cancer | AAC | 0.00092 | 1 |
| mRNA | Nilotinib | CCLE | pan-cancer | AAC | -0.0013 | 1 |
| mRNA | FQI-1 | CTRPv2 | pan-cancer | AAC | -0.001 | 1 |
| mRNA | tivantinib | CTRPv2 | pan-cancer | AAC | -0.00096 | 1 |
| mRNA | isoevodiamine | CTRPv2 | pan-cancer | AAC | 0.00066 | 1 |